Total Payments
$7,356
2024 Payments
$687.15
Companies
26
Transactions
224
Medicare Patients
6,710
Medicare Billing
$779,255
Payment Breakdown by Category
Food & Beverage$7,299 (99.2%)
Education$57.45 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,299 | 217 | 99.2% |
| Education | $57.45 | 7 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $1,053 | 10 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,023 | 13 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $920.51 | 45 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $869.41 | 48 | $0 (2024) |
| Boston Scientific Corporation | $723.35 | 7 | $0 (2019) |
| Amgen Inc. | $512.82 | 24 | $0 (2024) |
| PFIZER INC. | $468.39 | 16 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $455.21 | 23 | $0 (2024) |
| Medtronic, Inc. | $308.67 | 2 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $210.07 | 6 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $687.15 | 24 | Amgen Inc. ($194.53) |
| 2023 | $1,007 | 20 | Abbott Laboratories ($285.27) |
| 2022 | $482.46 | 9 | Medtronic, Inc. ($158.67) |
| 2021 | $356.33 | 4 | Abbott Laboratories ($192.87) |
| 2020 | $406.45 | 9 | Abbott Laboratories ($156.25) |
| 2019 | $1,394 | 31 | Boston Scientific Corporation ($420.81) |
| 2018 | $939.56 | 32 | Novartis Pharmaceuticals Corporation ($343.54) |
| 2017 | $2,083 | 95 | Boehringer Ingelheim Pharmaceuticals, Inc. ($610.61) |
All Payment Transactions
224 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/05/2024 | ShockWave Medical, Inc | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) | Food and Beverage | In-kind items and services | $27.72 | General |
| Category: Lithoplasty | ||||||
| 10/31/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $18.90 | General |
| 10/15/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: Cardiology | ||||||
| 09/26/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $22.11 | General |
| Category: Cardiology | ||||||
| 09/12/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $14.33 | General |
| Category: Cardiovascular | ||||||
| 09/05/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: Cardiology | ||||||
| 08/22/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $22.56 | General |
| 07/31/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $14.63 | General |
| Category: Cardiovascular | ||||||
| 07/25/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/19/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/18/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $26.75 | General |
| Category: Cardiology | ||||||
| 06/25/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: Cardiology | ||||||
| 06/20/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/30/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $23.95 | General |
| 05/20/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $80.21 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/14/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/06/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $25.38 | General |
| Category: Genetic Disease | ||||||
| 04/04/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $10.46 | General |
| Category: Cardiology | ||||||
| 03/07/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $27.75 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/09/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Renal Denervation System | ||||||
| 02/07/2024 | Abbott Laboratories | MITRACLIP (Device) | Food and Beverage | In-kind items and services | $23.88 | General |
| Category: Vascular | ||||||
| 01/25/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $29.07 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/18/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: Cardiology | ||||||
| 12/04/2023 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $26.69 | General |
| Category: Genetic Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 1,515 | 2,268 | $796,900 | $180,523 |
| 2022 | 14 | 1,639 | 2,390 | $792,088 | $185,712 |
| 2021 | 14 | 1,807 | 2,913 | $962,934 | $231,371 |
| 2020 | 16 | 1,749 | 2,817 | $787,521 | $181,649 |
Total Patients
6,710
Total Services
10,388
Medicare Billing
$779,255
Procedure Codes
54
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 306 | 569 | $244,670 | $63,408 | 25.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 313 | 333 | $309,010 | $60,545 | 19.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 275 | 508 | $147,320 | $39,893 | 27.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 325 | 447 | $53,640 | $5,830 | 10.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 35 | 35 | $23,100 | $4,784 | 20.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 183 | 286 | $4,290 | $2,387 | 55.6% |
| 93288 | Evaluation of single, dual, multiple lead or leadless pacemaker system | Office | 2023 | 27 | 39 | $5,850 | $1,795 | 30.7% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 23 | 23 | $7,130 | $1,435 | 20.1% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 14 | 14 | $1,120 | $296.10 | 26.4% |
| 93242 | Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 14 | 14 | $770.00 | $151.14 | 19.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 335 | 643 | $276,070 | $71,708 | 26.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 275 | 279 | $259,470 | $53,925 | 20.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 254 | 406 | $117,740 | $33,368 | 28.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 59 | 59 | $38,940 | $8,605 | 22.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 347 | 463 | $55,560 | $6,197 | 11.2% |
| 93288 | Evaluation of single, dual, multiple lead or leadless pacemaker system | Office | 2022 | 33 | 53 | $7,950 | $2,763 | 34.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 12 | 13 | $7,540 | $2,299 | 30.5% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2022 | 21 | 21 | $6,510 | $1,404 | 21.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 11 | 18 | $5,400 | $1,276 | 23.6% |
| 93289 | Evaluation of single, dual, or multiple lead implantable defibrillator system | Office | 2022 | 12 | 17 | $4,420 | $1,239 | 28.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 227 | 363 | $5,445 | $1,076 | 19.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 11 | 11 | $4,840 | $1,052 | 21.7% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2022 | 20 | 21 | $1,260 | $476.87 | 37.8% |
| 93242 | Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | Office | 2022 | 22 | 23 | $943.00 | $321.76 | 34.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 387 | 935 | $402,050 | $109,124 | 27.1% |
About Dr. William Schwartz, MD
Dr. William Schwartz, MD is a Cardiovascular Disease healthcare provider based in Long Island City, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1255367355.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Schwartz, MD has received a total of $7,356 in payments from pharmaceutical and medical device companies, with $687.15 received in 2024. These payments were reported across 224 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($7,299).
As a Medicare-enrolled provider, Schwartz has provided services to 6,710 Medicare beneficiaries, totaling 10,388 services with total Medicare billing of $779,255. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Long Island City, NY
- Active Since 06/23/2006
- Last Updated 08/01/2008
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1255367355
Products in Payments
- XARELTO (Drug) $869.41
- ENTRESTO (Drug) $848.44
- JARDIANCE (Drug) $640.33
- Mitra Clip system (Device) $421.98
- ELIQUIS (Drug) $398.65
- PRADAXA (Drug) $360.17
- Repatha (Biological) $325.86
- WATCHMAN (Device) $286.13
- AMPLATZER Occluders (Device) $192.87
- MITRACLIP (Device) $173.88
- WATCHMAN DEVICE (Device) $162.26
- CAMZYOS (Drug) $161.45
- COREVALVE EVOLUT R (Device) $158.67
- SYMPLICITY G3 (Device) $150.00
- MOMENTUM (Device) $149.96
- PRESSUREWIRE (Device) $135.27
- Barostim Neo System (Device) $135.17
- VRAYLAR (Drug) $127.78
- GLIDESHEATH SLENDER (Device) $125.16
- GENERAL TACHY (Device) $125.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.